Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation

Yanyiam, Peerawit; Kantachuvesiri, Surasak; Thammanichanond, Duangtawan

doi:10.1016/j.transproceed.2024.01.030

Transplantation Proceedings

2024

DOI: 10.1016/j.transproceed.2024.01.030

|View full text |Cite

Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation

Peerawit Yanyiam,

Surasak Kantachuvesiri,

Duangtawan Thammanichanond

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?

Niemann,

Matern

2024

Current Opinion in Organ Transplantation

View full text Add to dashboard Cite

Purpose of review Molecular matching continues to be an important topic in organ transplantation. Over the years, several studies – larger and smaller – supported correlations of molecular incompatibility loads and clinical outcomes. However, their practical utility for clinical decision making remains controversial and there is no consensus on the context in which they should be used. Recent findings The recent literature on molecular matching can be divided into four main areas of research: several groups present improvements of the algorithmic pipelines (1), increasing the robustness of previous findings. Further clinical evidence is reported (2) in various cohorts and other organ transplant domains, such as liver and lung transplantation. Consideration is given to the application of molecular matching in the allocation of deceased organs (3), suggesting options to improve allocation equity and utility. Furthermore, evidence is provided for personalized immunosuppression based on immunological risk (4), including infection and post graft failure management. Summary There is ample evidence that current molecular matching algorithms add value to immunologic risk stratification for organ transplant recipients. First studies on how to translate these insights into patient management with respect to organ allocation and personalized medicine are underway and require further support.

show abstract

Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?

Niemann,

Matern

2024

Current Opinion in Organ Transplantation

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation

Cited by 1 publication

References 19 publications

Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?

Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?

Contact Info

Product

Resources

About